New collaborations will increase access to SENTÉ’s patented sulfated glycosaminoglycan analog technology for aesthetic providers and their patients seeking innovative skin rejuvenation products Carlsbad, Calif., December 11, 2018 – SENTÉ, an innovative specialty aesthetics company,...

Read more

SAN DIEGO, Calif., October 24, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced the...

Read more

San Diego, Calif., Oct. 17, 2016 — SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced that the company...

Read more

SAN DIEGO, February 9, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment...

Read more

Capital To Further Expand Commercial Operations And Broaden Product Portfolio SAN DIEGO, February 5, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based...

Read more

SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) — SENTÉ a specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycosaminoglycans, today announced the appointment of Michael Brower to...

Read more

Aesthetic Industry Leader Brings Nearly Two Decades of Commercial and Marketing Expertise SAN DIEGO, July 22, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products...

Read more

Experienced Biopharmaceutical Industry Executive Adds to the Depth of the Company’s Board SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products...

Read more

Capital to Fund Expanded Commercial Operations and Broaden Product Portfolio SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on...

Read more

SAN DIEGO, Jul 11, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today the appointment of Michael York as...

Read more